The US is heavily reliant on China for its pharmaceutical supply chain, a situation that has raised concerns about national security risks.[6303051] The US is struggling to compete with China in the biotechnology race, with China investing aggressively in cutting-edge technologies such as artificial intelligence and synthetic biology.[6143135] Biotechnology is rapidly becoming a pillar of national power, and the US must take steps to address its dependence on China for pharmaceuticals if it wants to remain competitive.[6143135]